The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.70
Bid: 2.60
Ask: 2.80
Change: 0.00 (0.00%)
Spread: 0.20 (7.692%)
Open: 2.70
High: 2.70
Low: 2.70
Prev. Close: 2.70
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tern PLC: Device Authority Update - issue of further convertible loan

11 Apr 2019 07:00

Tern PLC (TERN) Tern PLC: Device Authority Update - issue of further convertible loan 11-Apr-2019 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


11 April 2019

 

Tern Plc (the "Company", or the "Group")

 

Device Authority Update - issue of further convertible loan

 

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), announces that, together with its co-investors, it has committed a further convertible secured loan to its portfolio company, Device Authority Limited ("DA"), which specialises in IoT security. The total funds secured by DA through this loan are US$418,895, of which Tern has contributed US$315,000.

 

Following this investment, Tern's total convertible secured loan note position with DA is US$2,415,867. The loan is repayable on 31 December 2019.

 

Tern's continued support is testament to DA's strong track record of using the funds that it has raised to deliver critical components of its go-to-market strategy. During 2018, DA enhanced its products to ensure that they met key client challenges and expanded its ecosystem of partners. DA has continued this trend in 2019 and has secured three new orders in Q1 through their partner network as well as consistently increasing annual recurring revenue quarter on quarter.

 

The loan note accrues an interest coupon of 5 per cent. per annum and is convertible automatically on completion of an equity fundraising by DA of at least US$2.5 million if completed before 31 December 2019 ("Qualifying Fundraising"). The conversion will be into the most senior class of shares issued in the Qualifying Fundraising at the lowest fundraising price per share.

 

If a Qualifying Fundraising is not completed before 31 December 2019, but DA is able to procure an exit for its shareholders, the providers of the loan can elect to either receive 300% of the principal amount of the loan notes held by them in addition to the accrued interest, or to convert the loan and accrued interest into Class A Preference Shares of DA at a conversion price of £0.036681585 per share.

 

Providers of this loan to DA will also be issued with 2.6 warrants for each US$1 of loan notes subscribed for by them (rounded down to the nearest whole number). Each warrant, which is exercisable at any time before 10 April 2026, provides each warrant holder with the right to subscribe for one Class A Preference Share of DA for each warrant held at an exercise price of £0.036681585 per share.

 

As part of this process, it has been agreed by all noteholders that all previous convertible loan notes provided to DA have their maturity date extended to 31 December 2019.

 

Al Sisto, CEO of Tern, said: "We are pleased with the progress that DA continues to make with its partners, including the recent contract win with nCipher Security to deliver a security solution for high quality surgical devices. The capital we provided in 2018, together with our co-investors, made a marked difference to DA as it set out to refine its product and expand its partnership network, leading to new contract wins in the second half of 2018 and into Q1 of 2019. With this in mind, we are pleased to continue this support and to maintain our holding as DA focuses on building its client base in the coming months."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

Enquiries

Tern Plc

Al Sisto/Sarah Payne

via Newgate Communications

 

Allenby Capital

(Nomad and joint broker)

David Worlidge/Alex Brearley

 

Tel: 020 3328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

Tel: 020 7659 1234

 

Newgate Communications

Elisabeth Cowell/Fiona Norman

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCM
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:8171
EQS News ID:798671
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Mar 20217:00 amRNSPortfolio News
11th Feb 20212:05 pmRNSSecond Price Monitoring Extn
11th Feb 20212:00 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSFundamentalVR and Device Authority Update
4th Feb 20217:00 amRNSPortfolio Update
28th Jan 20217:00 amRNSWyld Networks Fundraise and Update
15th Jan 202111:05 amRNSSecond Price Monitoring Extn
15th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20212:06 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:05 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSPortfolio Update
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:35 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSFurther FundamentalVR contract win
1st Dec 20205:30 pmRNSTotal Voting Rights
1st Dec 20207:00 amRNSFundamentalVR contract win
24th Nov 20207:00 amRNSFundamentalVR secures three-year follow on order
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 20207:00 amRNSResult of Fundraise
12th Nov 20204:36 pmRNSRetail Offer
12th Nov 20204:35 pmRNSEquity Fundraise of up to £2.2 million
10th Nov 20207:00 amRNSPortfolio Update
4th Nov 20207:00 amRNSInvestment in Talking Medicines Limited
2nd Nov 20204:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:35 pmRNSPrice Monitoring Extension
30th Oct 20204:41 pmRNSSecond Price Monitoring Extn
30th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Oct 20202:05 pmRNSSecond Price Monitoring Extn
30th Oct 20202:00 pmRNSPrice Monitoring Extension
14th Oct 20204:13 pmRNSHolding(s) in Company
14th Oct 20209:05 amRNSSecond Price Monitoring Extn
14th Oct 20209:00 amRNSPrice Monitoring Extension
12th Oct 20202:57 pmRNSHolding(s) in Company
30th Sep 20207:00 amEQSTern PLC: Device Authority convertible loan note maturity date extension
21st Sep 20207:00 amEQSTern PLC: (AIM: TERN) Unaudited Interim Results for the six months to 30 June 2020
17th Sep 20207:01 amEQSTern PLC: Change of Adviser
9th Sep 20207:00 amEQSTern PLC: Wyld Networks awarded initial purchase order for satellite IoT deployment
27th Aug 20207:00 amEQSTern PLC: InVMA appoints new CEO and secures Future Fund convertible loan Investment of £125,000 in InVMA
26th Aug 20207:00 amEQSTern PLC: Questions & Answers published on website
6th Aug 20207:00 amEQSTern PLC: Contract Win for Device Authority
3rd Aug 20204:00 pmEQSTern PLC: Holding (s) in Company
31st Jul 20205:00 amEQSTern PLC: Total Voting Rights
20th Jul 20202:06 pmRNSSecond Price Monitoring Extn
20th Jul 20202:00 pmRNSPrice Monitoring Extension
20th Jul 20209:00 amEQSTern PLC: Subscription for £1.5 million and H1 2020 Portfolio Update
24th Jun 202011:05 amRNSSecond Price Monitoring Extn
24th Jun 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.